These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39271690)

  • 1. Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay.
    Schmidt S; Geisel A; Enzlein T; Fröhlich BC; Pritchett L; Verneret M; Graf C; Hopf C
    Sci Rep; 2024 Sep; 14(1):21462. PubMed ID: 39271690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast Nanoliter-Scale Cell Assays Using Droplet Microarray-Mass Spectrometry Imaging.
    RamalloGuevara C; Paulssen D; Popova AA; Hopf C; Levkin PA
    Adv Biol (Weinh); 2021 Mar; 5(3):e2000279. PubMed ID: 33729695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of Microbial Colonies for High-Throughput Engineering of Multistep Enzymatic Reactions via Optically Guided Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry.
    Si T; Li B; Comi TJ; Wu Y; Hu P; Wu Y; Min Y; Mitchell DA; Zhao H; Sweedler JV
    J Am Chem Soc; 2017 Sep; 139(36):12466-12473. PubMed ID: 28792758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors.
    Winter M; Simon RP; Wang Y; Bretschneider T; Bauer M; Magarkar A; Reindl W; Fernández-Montalván A; Montel F; Büttner FH
    SLAS Discov; 2022 Jul; 27(5):287-297. PubMed ID: 35597517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Cheng Z; Winant RC; Gambhir SS
    J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins.
    Moore LM; Cho S; Thoren KL
    Clin Chim Acta; 2019 May; 492():91-94. PubMed ID: 30790545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis.
    Marvin-Guy LF; Duncan P; Wagnière S; Antille N; Porta N; Affolter M; Kussmann M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1099-108. PubMed ID: 18335464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A label-free MALDI TOF MS-based method for studying the kinetics and inhibitor screening of the Alzheimer's disease drug target β-secretase.
    Machálková M; Schejbal J; Glatz Z; Preisler J
    Anal Bioanal Chem; 2018 Nov; 410(28):7441-7448. PubMed ID: 30218128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI-TOF MS as a label-free approach to rapid inhibitor screening.
    Greis KD; Zhou S; Burt TM; Carr AN; Dolan E; Easwaran V; Evdokimov A; Kawamoto R; Roesgen J; Davis GF
    J Am Soc Mass Spectrom; 2006 Jun; 17(6):815-822. PubMed ID: 16616859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing MALDI-TOF as Versatile Drug Discovery Readout to Dissect the PTP1B Enzymatic Reaction.
    Winter M; Bretschneider T; Kleiner C; Ries R; Hehn JP; Redemann N; Luippold AH; Bischoff D; Büttner FH
    SLAS Discov; 2018 Jul; 23(6):561-573. PubMed ID: 29466676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-free cell assays to determine compound uptake or drug action using MALDI-TOF mass spectrometry.
    Unger MS; Blank M; Enzlein T; Hopf C
    Nat Protoc; 2021 Dec; 16(12):5533-5558. PubMed ID: 34759382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond.
    Haslam C; Hellicar J; Dunn A; Fuetterer A; Hardy N; Marshall P; Paape R; Pemberton M; Resemannand A; Leveridge M
    J Biomol Screen; 2016 Feb; 21(2):176-86. PubMed ID: 26428484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow.
    van den Broek I; Nouta J; Razavi M; Yip R; Bladergroen MR; Romijn FP; Smit NP; Drews O; Paape R; Suckau D; Deelder AM; van der Burgt YE; Pearson TW; Anderson NL; Cobbaert CM
    Methods; 2015 Jun; 81():74-85. PubMed ID: 25766926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.
    Tsuchida S; Umemura H; Nakayama T
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33080897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of an In Situ MALDI-Based High-Throughput Screening Process: A Case Study with Receptor Tyrosine Kinase c-MET.
    Beeman K; Baumgärtner J; Laubenheimer M; Hergesell K; Hoffmann M; Pehl U; Fischer F; Pieck JC
    SLAS Discov; 2017 Dec; 22(10):1203-1210. PubMed ID: 28820955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct identification of trypanosomatids by matrix-assisted laser desorption ionization-time of flight mass spectrometry (DIT MALDI-TOF MS).
    Avila CC; Almeida FG; Palmisano G
    J Mass Spectrom; 2016 Aug; 51(8):549-57. PubMed ID: 27659938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS.
    Simon RP; Winter M; Kleiner C; Ries R; Schnapp G; Heimann A; Li J; Zuvela-Jelaska L; Bretschneider T; Luippold AH; Reindl W; Bischoff D; Büttner FH
    SLAS Discov; 2020 Apr; 25(4):372-383. PubMed ID: 31583948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1.
    Müller L; Burton AK; Tayler CL; Rowedder JE; Hutchinson JP; Peace S; Quayle JM; Leveridge MV; Annan RS; Trost M; Peltier-Heap RE; Dueñas ME
    SLAS Discov; 2023 Jan; 28(1):3-11. PubMed ID: 36414185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated analysis of lipid drug-response markers by combined fast and high-resolution whole cell MALDI mass spectrometry biotyping.
    Weigt D; Sammour DA; Ulrich T; Munteanu B; Hopf C
    Sci Rep; 2018 Jul; 8(1):11260. PubMed ID: 30050068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput nucleoside phosphate monitoring in mammalian cell fed-batch cultivation using quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Steinhoff RF; Ivarsson M; Habicher T; Villiger TK; Boertz J; Krismer J; Fagerer SR; Soos M; Morbidelli M; Pabst M; Zenobi R
    Biotechnol J; 2015 Jan; 10(1):190-8. PubMed ID: 25139677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.